New drug aims to stop kidney rejection without lifelong side effects
Disease control
Not yet recruiting
This early study tests a new medication called TNX-1500 in 5 people receiving a kidney transplant. The goal is to see if it is safe and can help prevent the body from rejecting the new kidney. Participants will be followed for one year to check for side effects and signs of rejec…
Phase: PHASE2 • Sponsor: Ayman Al Jurdi, MD • Aim: Disease control
Last updated May 04, 2026 04:05 UTC